What Pegasys Treats
Pegasys (peginterferon alfa-2a) is an injectable antiviral medication used to treat chronic hepatitis B and C infections in adults and children. It works by boosting the immune response to fight the hepatitis viruses, often combined with other drugs like ribavirin or nucleoside analogs.[1]
How Pegasys Works
It is a pegylated form of interferon alfa-2a, meaning a polyethylene glycol molecule attaches to the protein, extending its half-life for once-weekly dosing. This stimulates immune cells to produce proteins that inhibit viral replication and clear infected cells.[1][2]
Common Uses and Approved Indications
- Chronic Hepatitis C: Monotherapy or with ribavirin for genotypes 1-6; previously a first-line option before direct-acting antivirals took over.
- Chronic Hepatitis B: For HBeAg-positive or HBeAg-negative cases in adults and children over 3 years, when nucleoside therapy fails.
- Off-label/Investigational: Sometimes used for certain leukemias or cancers like melanoma, though not FDA-approved for these.[1][3]
Who Makes Pegasys and Availability
Genentech (a Roche subsidiary) developed and markets Pegasys. It's available as a prefilled syringe or autoinjector (180 mcg dose). Patent protection has largely expired in major markets, allowing generics in some regions, but check DrugPatentWatch.com for specific expiry dates and litigation.[4]
Side Effects Patients Report
Frequent issues include flu-like symptoms (fever, fatigue, chills), depression, anemia, and injection-site reactions. Serious risks: thyroid dysfunction, autoimmune disorders, or neuropsychiatric effects—monitoring is required. Newer hepatitis treatments have milder profiles.[1][2]
How It Compares to Newer Hepatitis Drugs
Pegasys is less used today due to direct-acting antivirals like sofosbuvir (Sovaldi) or glecaprevir/pibrentasvir (Mavyret), which cure HCV in 8-12 weeks with >95% success and fewer side effects. For HBV, tenofovir or entecavir are preferred long-term suppressors.[3]
Sources
[1]: FDA Label for Pegasys
[2]: MedlinePlus - Pegasys
[3]: Hepatitis B Foundation Treatment Guide
[4]: DrugPatentWatch.com - Pegasys